 | Up a level |
Piguet, Anne-Christine; Guarino, Maria; Potaczek, Daniel P; Garn, Holger; Dufour, Jean-François (2019). Hepatic gene expression in mouse models of non-alcoholic fatty liver disease after acute exercise. Hepatology research, 49(6), pp. 637-652. Wiley 10.1111/hepr.13323
Piguet, Anne-Christine; Medova, Michaela; Keogh, Adrian; Glück, Astrid Andreina; Aebersold, Daniel; Dufour, Jean-François; Dufour, Jean-François; Zimmer, Yitzhak (2015). Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer. Genes & cancer, 6(7-8), pp. 317-327. Impact Journals
Sieghart, Wolfgang; Pinter, Matthias; Dauser, Bernhard; Rohr-Udilova, Natalya; Piguet, Anne-Christine; Prager, Gerald; Hayden, Hubert; Dienes, Hans-Peter; Dufour, Jean-François; Peck-Radosavljevic, Markus (2012). Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma. Journal of hepatology, 57(3), pp. 592-9. Amsterdam: Elsevier 10.1016/j.jhep.2012.04.034
Piguet, Anne-Christine; Saar, Bettina; Hlushchuk, Ruslan; St-Pierre, Marie V; McSheehy, Paul M J; Radojevic, Vesna; Afthinos, Maresa; Terracciano, Luigi; Djonov, Valentin; Dufour, Jean-François (2011). Everolimus augments the effects of sorafenib in a syngeneic orthotopic model of hepatocellular carcinoma. Molecular cancer therapeutics, 10(6), pp. 1007-17. Philadelphia, Pa.: American Association for Cancer Research AACR 10.1158/1535-7163.MCT-10-0666
Piguet, Anne-Christine; Dufour, Jean-François (2011). PI(3)K/PTEN/AKT pathway. Journal of hepatology, 54(6), pp. 1317-9. Amsterdam: Elsevier 10.1016/j.jhep.2010.12.013
Piguet, Anne-Christine; Stroka, Deborah; Zimmermann, Arthur; Dufour, Jean-François (2010). Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN. Clinical science, 118(6), pp. 401-10. London: Portland 10.1042/CS20090313
Piguet, Anne-Christine; Semela, David; Keogh, Adrian; Wilkens, Ludwig; Stroka, Deborah; Stoupis, Christoforos; St-Pierre, Marie V; Dufour, Jean-François (2008). Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma. Journal of hepatology, 49(1), pp. 78-87. Amsterdam: Elsevier 10.1016/j.jhep.2008.03.024
Romanque, Pamela; Piguet, Anne-Christine; Dufour, Jean-François (2008). Targeting vessels to treat hepatocellular carcinoma. Clinical science, 114(7), pp. 467-77. London: Portland 10.1042/CS20070310
Semela, David; Piguet, Anne-Christine; Kolev, Mirjam; Schmitter, Karin; Hlushchuk, Ruslan; Djonov, Valentin; Stoupis, Christoforos; Dufour, Jean-François (2007). Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma. Journal of hepatology, 46(5), pp. 840-8. Amsterdam: Elsevier 10.1016/j.jhep.2006.11.021
Roth, Patrik; Hammer, Caroline; Piguet, Anne-Christine; Ledermann, Monika; Dufour, Jean-François; Waelti, Ernst (2007). Effects on hepatocellular carcinoma of doxorubicin-loaded immunoliposomes designed to target the VEGFR-2. Journal of drug targeting, 15(9), pp. 623-31. London: Informa Healthcare 10.1080/10611860701502723
Martin, Juliette; Magnino, Fabrice; Schmidt, Karin; Piguet, Anne-Christine; Lee, Ju-Seog; Semela, David; St-Pierre, Marie V; Ziemiecki, Andrew; Cassio, Doris; Brenner, Charles; Thorgeirsson, Snorri S; Dufour, Jean-François (2006). Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma. Gastroenterology, 130(7), pp. 2179-88. Philadelphia, Pa.: Elsevier 10.1053/j.gastro.2006.03.004
